BD Diagnostics Fiscal Q1 Revenues Rise 3 Percent | GenomeWeb

Becton Dickinson said this week that revenues for its BD Diagnostics unit increased 3 percent year-over-year in the first quarter of fiscal year 2014, helping to drive an overall 6 percent spike in company revenues.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.